Embecta Corp. (EMBC)
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Instruments & Supplies
Embecta Corp.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 6.11 | 6.39 | 5.78 | 6.19 | 623,134 |
| Nov 5, 2026 | 6.58 | 6.66 | 6.23 | 6.33 | 780,109 |
| Nov 4, 2026 | 6.25 | 6.79 | 6.20 | 6.52 | 1,153,755 |
| Nov 3, 2026 | 6.17 | 6.29 | 6.05 | 6.08 | 570,291 |
| Nov 2, 2026 | 6.28 | 6.36 | 6.13 | 6.19 | 658,224 |
| Oct 30, 2026 | 6.55 | 6.58 | 6.20 | 6.25 | 831,097 |
| Oct 29, 2026 | 6.52 | 6.70 | 6.45 | 6.56 | 1,108,546 |
| Oct 28, 2026 | 6.54 | 6.60 | 6.37 | 6.46 | 985,001 |
| Oct 27, 2026 | 6.80 | 6.89 | 6.49 | 6.55 | 1,277,578 |
| Oct 26, 2026 | 6.70 | 6.83 | 6.65 | 6.80 | 679,490 |
| Oct 23, 2026 | 6.77 | 6.88 | 6.69 | 6.71 | 717,025 |
| Oct 22, 2026 | 6.64 | 6.90 | 6.63 | 6.86 | 922,041 |
| Oct 21, 2026 | 6.37 | 6.74 | 6.35 | 6.68 | 706,692 |
| Oct 20, 2026 | 6.29 | 6.51 | 6.21 | 6.42 | 746,145 |
| Oct 19, 2026 | 6.39 | 6.39 | 6.20 | 6.21 | 899,657 |
| Oct 16, 2026 | 6.51 | 6.53 | 6.26 | 6.27 | 622,681 |
| Oct 15, 2026 | 6.19 | 6.58 | 6.19 | 6.45 | 983,710 |
| Oct 14, 2026 | 6.19 | 6.25 | 6.11 | 6.18 | 651,477 |
| Oct 13, 2026 | 6.01 | 6.24 | 5.92 | 6.20 | 732,864 |
| Oct 12, 2026 | 5.77 | 6.11 | 5.77 | 5.99 | 1,053,591 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Morris Milton Mayo | Director | Sale | 6.3K | $37.0K | Sep 4, 2026 |
 Elguicze Jacob | SVP and CFO | Purchase | 20.0K | $93.4K | Aug 12, 2026 |
 Kurdikar Devdatt | President and CEO | Purchase | 30.0K | $140.9K | Aug 12, 2026 |
 Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO | Purchase | 20.0K | $99.8K | Aug 12, 2026 |
 HOMBACH ROBERT J. | Director | Purchase | 45.0K | $223.8K | Aug 12, 2026 |
 Casner Jean | Chief Human Resources Officer | Automatic Sell | 1.5K | $6.5K | Aug 9, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 4.6M | 8.1% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2026 | 4.6M | 8.0% | 13G |
YACKTMAN ASSET MANAGEMENT LP | 4.3M | 7.7% | 13F |
American Century Investment Management, Inc. · joint filing· may incl. warrants· filed May 2026 | 3.4M | 6.1% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | 4.5% | 13F |
DEERFIELD MANAGEMENT COMPANY, L.P. | 2.5M | 4.5% | 13F |
Jefferies Financial Group Inc. | 2.4M | 4.2% | 13F |
AMERIPRISE FINANCIAL INC | 2.0M | 3.6% | 13F |
MORGAN STANLEY | 2.0M | 3.5% | 13F |
STATE STREET CORP | 1.6M | 2.8% | 13F |
Insiders
- Morris Milton MayoDirector
- Elguicze JacobSVP and CFO
- Kurdikar DevdattPresident and CEO
- Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLO
- HOMBACH ROBERT J.Director
- Casner JeanChief Human Resources Officer
- Roth Anthony M.VP, Chief Accounting Officer
- Reidy Christopher RDirector
- Pomeroy ClaireDirector
- Anderson Carrie LDirector
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes.
Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices.
Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey.
The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
based on 56.66M shares outstanding
US30d Avg
835.15K
60d Avg
939.60K
90d Avg
1.12M